Bicarbonate

Bicarbonate

SCHEMBL18167232

Cc1noc(-c2ccc(-c3ccc(C4CC4)cc3)cc2)c1CN1C(=O)OC[C@@H]1c1ccccc1.O=C(O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SCD5 Q86SK9 1/20 0.47
HDAC1 Q13547 2/20 0.42
PTGDR2 Q9Y5Y4 3/20 0.37
GLS O94925 4/20 0.36
SLC6A9 P48067 1/20 0.36
BRD4 O60885 5/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL18167197 0.87 HDAC1 (0.44) SCD5HDAC1PTGDR2SLC6A9
SCHEMBL3309 0.85 SCD5 (0.45) SCD5HDAC1PTGDR2GLS
SCHEMBL14779471 0.85 SCD5 (0.45) SCD5HDAC1PTGDR2GLS
Bicarbonate SCHEMBL18167237 0.83 PTGDR2 (0.41) PTGDR2SLC6A9BRD4NPC1RAB9A
Bicarbonate SCHEMBL18167218 0.83 PTGDR2 (0.41) PTGDR2SLC6A9BRD4NPC1RAB9A
Bicarbonate SCHEMBL18167217 0.81 OGA (0.45) SCD5NPC1RAB9A
SCHEMBL3778 0.81 SCD5 (0.42) SCD5HDAC1PTGDR2
SCHEMBL14778153 0.81 SCD5 (0.42) SCD5HDAC1PTGDR2
Bicarbonate SCHEMBL18167182 0.80 ACKR3 (0.44) SCD5
Bicarbonate SCHEMBL18167234 0.80 FADS1 (0.41) HDAC1PTGDR2SLC6A9BRD4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483251-B1 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS INC (US) 2016-10-26 EP claimed